Although there has been widespread talk of using hydroxychloroquine, an anti-malarial drug, to combat Covid-19, a study has proven to be ineffective, and that its use may involve real risks. "We have found no evidence that the use of hydroxychloroquine, with or without azithromycin (an antimalarial drug), reduces the risk of mechanical ventilation in patients with Covid-19 who are hospitalized," the researchers said in a new study supported by the US National Institutes of Health and the University of Virginia. ».
According to the Dubai Future Observatory, the team wrote in its study, "The use of hydroxychloroquine alone is linked to an increased risk of death compared to standard care alone."
The study included data on 368 patients with "Covid-19" at the Veterans Hospital. 27.8% of those treated with the drug died, and only 11.4% of those who received standard therapy died.
But the authors of the study advise people to be careful, and they said, "These results highlight the importance of waiting for the results of future studies before circulating medications."
The US Centers for Disease Control and Prevention recently removed the dosage instructions for Hydroxychloroquine from its website.
A French study found that "there is no evidence of rapid antiviral activity or clinical benefit."